Michael Rome

Director/Board Member at

Remix Therapeutics, Inc.

Health Technology

Consumer Services

Finance

Profile

Michael Rome is currently Director at Remix Therapeutics, Inc., Director at Pharvaris GmbH since 2020, Director at XinThera, Inc. since 2021, and Managing Director at Foresite Capital Management LLC since 2016.
Former positions include Director at Maze Therapeutics, Inc. and Alumis, Inc., Director at Pharvaris NV from 2019 to 2020, Independent Director at Theseus Pharmaceuticals, Inc. from 2021 to 2024, Independent Director at Kinnate Biopharma, Inc. from 2019 to 2024, and Director & Vice President at FS Development Corp.
from 2020 to 2021.
Education includes a doctorate from California Institute of Technology and an undergraduate degree from the University of California.

Michael Rome active positions

Companies	Position	Start
Foresite Capital Management LLC Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for seed and later stage capital requirements.	Private Equity Investor	01/08/2016
Pharvaris GmbH Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Director/Board Member	01/07/2020
Remix Therapeutics, Inc. Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases	Director/Board Member	-
Xinthera, Inc. Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Produces novel oncology and immunology drugs	Director/Board Member	01/01/2021

All active positions of Michael Rome

Former positions of Michael Rome

Companies	Position	End
KINNATE BIOPHARMA INC.	Director/Board Member	03/04/2024
THESEUS PHARMACEUTICALS, INC.	Director/Board Member	14/02/2024
FS DEVELOPMENT CORP.	Director/Board Member	01/02/2021
PHARVARIS N.V.	Director/Board Member	31/12/2020
ALUMIS INC.	Director/Board Member	-

See the detail of Michael Rome's experience

Training of Michael Rome

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Rome's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
California Institute of Technology California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Foresite Capital Management LLC Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management invests in companies located in the United States. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for seed and later stage capital requirements.	Finance
University of California University of California Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pharvaris NV Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists	Health Technology
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients	Health Technology
Maze Therapeutics, Inc. Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases	Health Technology
Kinnate Biopharma, Inc. Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company	Health Technology
FS Development Corp. FS Development Corp. Financial ConglomeratesFinance Operates as a blank check company	Finance
Remix Therapeutics, Inc. Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases	Health Technology
Pharvaris GmbH Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Alumis, Inc. Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders	Health Technology
Xinthera, Inc. Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Produces novel oncology and immunology drugs	Health Technology